APA (7th ed.) Citation

Garcia, J. S., Platzbecker, U., Odenike, O., Fleming, S., Fong, C. Y., Borate, U., . . . Garcia-Manero, G. (2025). Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes. Blood, 145(11), . https://doi.org/10.1182/blood.2024025464

Chicago Style (17th ed.) Citation

Garcia, Jacqueline S., et al. "Efficacy and Safety of Venetoclax Plus Azacitidine for Patients with Treatment-naive High-risk Myelodysplastic Syndromes." Blood 145, no. 11 (2025). https://doi.org/10.1182/blood.2024025464.

MLA (9th ed.) Citation

Garcia, Jacqueline S., et al. "Efficacy and Safety of Venetoclax Plus Azacitidine for Patients with Treatment-naive High-risk Myelodysplastic Syndromes." Blood, vol. 145, no. 11, 2025, https://doi.org/10.1182/blood.2024025464.